1
Main outcome measure: Cardiac and stroke mortality were our main outcome measures.
2
Main outcomes and measures: The main outcome measure was facial nerve weakness.
3
Main outcome measure: The primary outcome measure was moderate to severe CP.
4
Main outcome measure: Diagnosis of AD by means of multistage assessment procedures.
5
Main outcome measure: Two year survival after onset of acute lung injury.
6
The main outcome measure was the number of days with persistent cough.
7
Main outcome measure: Unplanned readmission to the study hospital within 6 months.
8
Main outcome measure: The development of a clinical prediction rule for GDM.
9
Main outcome measure: All-cause mortality at a mean follow-up of 37 months.
10
Main outcome measure: Pupil response parameter comparison between mutation carriers and non-carriers.
11
The primary outcome measure was number of days in 14 with MODS.
12
Main outcome measure: Incident AD diagnosed in clinical evaluations with standardized criteria.
13
Main outcome measure: Reduction in the prevalence of congenital disorders at birth.
14
Both used a six minute walk test as the primary outcome measure.
15
Data-extraction and analysis: The primary outcome measure was the number of complications.
16
Main outcome measure: The E-FABP concentrations were compared between patients and controls.